Scientists have turned skin cells into stem cells that can hunt down and destroy the deadly remains inevitably left behind when a glioblastoma is removed.
Drug-resistant leukemia cells absorb a drug and die, when the drug is hidden inside a capsule made of folded up DNA.
An international team of researchers has seen "extraordinary" results using patients' own immune cells to fight cancer. In one trial, 94 percent of patients with acute lymphoblastic leukaemia saw their symptoms disappear entirely.
Physicians and biomedical engineers from Johns Hopkins report what they believe is the first successful effort to wiggle fingers individually and independently of each other using a mind-controlled artificial "arm" to control the movement.
Scientists have developed an innovative 3D bioprinter capable of generating replacement tissue that's strong enough to withstand transplantation. To show its power, the scientists printed a jaw bone, muscle, and cartilage structures, as well as a stunningly accurate human ear.
Researchers at Johns Hopkins Bloomberg School of Public Health have produced tiny brains made of human neurons and cells. These mini-brains could radically change how drugs are tested, replacing the many animals currently being used for neurological scientific research.
In the relentless torrent of high technology news that rushes past each day, it can be easy to miss the good stuff. For example, the debut of a cleverly designed exoskeleton that helps paraplegics walk again — and that the average person can actually afford.
For those with type 1 diabetes, regularly injecting themselves with insulin is part and parcel of their daily lives. This form of treatment hasn't advanced much for nearly a century, so it will come as good news that researchers at the Massachusetts Institute of Technology (MIT) are on the verge of a breakthrough.
Anxiety disorder is the most common mental illness, affecting at least one in five adults. In their latest study, scientists at the Max Planck Institute of Psychiatry in Munich have shown that an enzyme called Dnmt3a is crucial in how the frontal cortex mediates stress-induced anxiety. Manipulation of this enzyme might represent a new therapeutic target.
Overlooked brain area has a 'motherlode' of autism genes. These genes are mutated Rbfox1 - which regulates cell proteins. When Rbfox1 genes 'go awry', it can increase the risk of autism. Scientists discovered a region of cells full packed with Rbfox1 genes. This finding provides fresh drug targets for new therapies.
In the next decade, people who have suffered a spinal cord injury or stroke could have their mobility improved or even restored through a radically new technology: implantable devices that can send signals between regions of the brain or nervous system that have been disconnected due to injury.
We are experiencing a new wave of innovation in health care - one that promises to create the smartest, most connected, and most efficient health systems the world has ever seen.
With this leukemia reversal, gene editing has now demonstrated remarkable promise and fueled optimism about future uses. But experts urge caution.
For the first time, scientists have created mini-kidneys from stem cells. They want to use the tissues to test drugs to treat kidney disease.
A team at Manchester Royal Infirmary hospital, England, claim to be the first surgeons to use 3D cameras and monitors -- and embarrassingly clunky spectacles -- during an operation. Furthermore, if that wasn
